The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine
Open accessPublished version of a preprint
Abstract
Clinically relevant subtypes exist for pancreatic ductal adenocarcinoma (PDAC), but molecular characterization is not yet standard in clinical care. We implemented a biopsy protocol to perform time-sensitive whole-exome sequencing and RNA sequencing for patients with advanced PDAC. Therapeutically relevant genomic alterations were identified in 48% (34/71) and pathogenic/likely pathogenic germline alterations in 18% (13/71) of patients. Overall, 30% (21/71) of enrolled patients experienced a change in clinical management as a result of genomic data. Twenty-six patients had germline and/or somatic alterations in DNA-damage repair genes, and 5 additional patients had mutational signatures of homologous recombination deficiency but no identified causal genomic alteration. Two patients had oncogenic in-frame BRAF deletions, and we report the first clinical evidence that this alteration confers sensitivity to MAPK pathway inhibition. Moreover, we identified tumor/stroma gene expression signatures with clinical relevance. Collectively, these data demonstrate the feasibility and value of real-time genomic characterization of advanced PDAC. Significance: Molecular analyses of metastatic PDAC tumors are challenging due to the heterogeneous cellular composition of biopsy specimens and rapid progression of the disease. Using an integrated multidisciplinary biopsy program, we demonstrate that real-time genomic characterization of advanced PDAC can identify clinically relevant alterations that inform management of this difficult disease. Cancer Discov; 8(9); 1096–111. ©2018 AACR. See related commentary by Collisson, p. 1062. This article is highlighted in the In This Issue feature, p. 1047
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there are also so-called “alternative drivers” found in the 8–10% of cases that are KRAS wild type104,105.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Self-citationSensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D. B., Sougnez, C. L., Gabriel, S., Meyerson, M. M., Lander, E. S., & Getz, G. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,965
Self-citationCore Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621 · cited 2×
“As has been suggested in prior studies of primary PDAC resection specimens (7,9,12), we observed a striking prevalence of germline and somatic mutations in DDR genes in our cohort of advanced PDAC patients.”
BackgroundResultMermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. M., Beroukhim, R., & Getz, G. A. (2011) · Genome biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,520
Self-citationOlive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationCombined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
Flaherty, K. T., Infante, J. R., Daud, A., Gonzalez, R., Kefford, R. F., Sosman, J., Hamid, O., Schuchter, L., Cebon, J., Ibrahim, N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210093 · Cited by 2,810
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Cited by
Sorted by citations
Items 201–300 of 366
Raghavan, S., Winter, P. S., Navia, A. W., Williams, H. L., DenAdel, A., Kalekar, R. L., Galvez-Reyes, J., Lowder, K. E., Mulugeta, N., Raghavan, M. S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.25.256214 · Cited by 10
Self-citationWang, X., Breuer, J., Garbe, S., Giordano, F. A., Brossart, P., Feldmann, G., & Bisht, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116249 · Cited by 10
A Systematic Review of Real-Time Deep Learning Methods for Image-Based Cancer Diagnostics
Sriraman, H., Saleena, B., Vats, S., & Balasubramanian, P. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s446745 · Cited by 12
Using 3D-bioprinted models to study pediatric neural crest-derived tumors
Quinn, C. H., Beierle, A. M., Julson, J. R., Erwin, M. H., Alrefai, H., Markert, H. R., Stewart, J. E., Hutchins, S. C., Bownes, L. V., Aye, J. M., et al. (2023) · International Journal of Bioprinting · doi:10.18063/ijb.723 · Cited by 9
Targeted Therapy for BRAF V600E Positive Pancreatic Adenocarcinoma: Two Case Reports
Shah, S., Rana, T., Kancharla, P., & Monga, D. K. (2023) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20391 · Cited by 9
Steiner, S., Pliego‐Mendieta, A., Haberecker, M., Hussung, S., Kollár, A., Fritsch, R., Arnold, F. M., Lenggenhager, D. M., Planas‐Paz, L., & Pauli, C. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216650 · Cited by 10
Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice?
Krepline, A. N., Bliss, L. A., Geurts, J. L., Akinola, I. M., Christians, K. K., George, B., Ritch, P. S., Hall, W. A., Erickson, B. A., Evans, D. B., et al. (2019) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04423-6 · Cited by 9
Melisi, D., Cavaliere, A., Gobbo, S., Fasoli, G., Allegrini, V., Simionato, F., Gaule, M., Casalino, S., Pesoni, C., Zecchetto, C., et al. (2021) · Pancreatology · doi:10.1016/j.pan.2021.04.004 · Cited by 9
Du, J., Qiu, X., Lu, C., Zhu, Y., Kong, W., Xu, M., Zhang, X., Tang, M., Chen, J., Li, Q., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.844527 · Cited by 10
The role of PARP inhibitors in germline BRCA-associated pancreatic ductal adenocarcinoma.
Moffat, G. T., & O'Reilly, E. M. (2020) · PubMed · Cited by 8
Bispo, M., Marques, S., Rio‐Tinto, R., Fidalgo, P. O., & Deviere, J. M. E. (2020) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000509197 · Cited by 8
Kawalerski, R. R., Leach, S. D., & Escobar‐Hoyos, L. F. (2021) · Oncotarget · doi:10.18632/oncotarget.27901 · Cited by 8
Refining Classification of Pancreatic Cancer Subtypes to Improve Clinical Care
Aguirre, A. J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.11.004 · Cited by 8
Self-citationLin, B., Pan, Y., Yu, D., Dai, S., Sun, H., Chen, S., Zhang, J., Xiang, Y., & Huang, C. (2021) · BioMed Research International · doi:10.1155/2021/5573628 · Cited by 8
Beyond the Front Line: Emerging Data for Maintenance Therapy in Pancreatic Cancer
Singh, H., Perez, K. J., Wolpin, B. M., & Aguirre, A. J. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.01510 · Cited by 7
Self-citationWu, W., Liu, Y., Jin, Y., Liu, L., Guo, Y., Xu, M., Hao, Q., Li, D., Fang, W. J., Zhang, A., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.746637 · Cited by 8
Ohyama, H., Mikata, R., Hirotsu, Y., Amemiya, K., Miura, Y., Hirose, S., Oyama, T., Takano, A., Iimuro, Y., Kojima, Y., et al. (2022) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2022.152016 · Cited by 7
Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal Adenocarcinoma
Zerdan, M. B., Shatila, M., Sarwal, D., Bouferraa, Y., Zerdan, M. B., Allam, S., Ramovic-Zobic, M., & Graziano, S. L. (2022) · Cancers · doi:10.3390/cancers14194589 · Cited by 7
Ghazani, A. A., Breen, K. M., Dwan, M., Barletta, J. A., Vatnick, D. R., Stokes, S. M., Block, C. C., Doherty, G. M., Cohn, A. Y., Marqusee, E., et al. (2020) · American Journal of Case Reports · doi:10.12659/ajcr.927415 · Cited by 7
Self-citationThe EUS molecular evaluation of pancreatic cancer: A prospective multicenter cohort trial
Croagh, D. G., Masoumi-Moghaddam, S., Lundy, J., Gao, H., Rathi, V., Swan, M. P., Desmond, C., Bhutani, M., Southey, M., Vaughan, R., et al. (2021) · Endoscopic Ultrasound · doi:10.4103/eus-d-20-00230 · Cited by 7
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
Merz, V., Mangiameli, D., Zecchetto, C., Quinzii, A., Pietrobono, S., Messina, C. G. M., Casalino, S., Gaule, M., Pesoni, C., Vitale, P., et al. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.866173 · Cited by 7
Hill, A., & Chung, V. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-31471-2_6 · Cited by 7
Mouawad, A., Habib, S., Boutros, M., Attieh, F., & Kourié, H. R. (2024) · Future Oncology · doi:10.1080/14796694.2024.2355078 · Cited by 6
Pulvirenti, A., Barbagallo, M., Putignano, A. R., Pea, A., Polidori, R., Upstill‐Goddard, R., Cortese, N., Kunderfranco, P., Brunelli, L., Simone, G. D., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1405612 · Cited by 6
Barrambana, S., Zamorano-Domínguez, E., Liaki, V., & Guerra, C. E. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115652 · Cited by 8
Thalji, S. Z., Aldakkak, M., Ramamurthi, A., Jaraczewski, T. J., Belbahri, M., SenthilKumar, G., Shaik, T., Merrill, J. R., Banerjee, A., Taylor, B., et al. (2026) · JAMA Surgery · doi:10.1001/jamasurg.2026.0291 · Cited by 6
Precision Medicine and Pancreatic Cancer
George, B. (2021) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2021.06.008 · Cited by 6
Oncogenic dependency plays a dominant role in the immune response to cancer
Li, J., D’Amico, S., Kirillov, V., Petrenko, O., & Reich, N. C. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2308635120 · Cited by 6
Evolution of oncosurgical management of pancreatic cancer
Klaiber, U., Roth, S., Hackert, T., & Neoptolemos, J. P. (2019) · European surgery. Supplement/European surgery · doi:10.1007/s10353-019-0587-8 · Cited by 6
Huang, L., Bockorny, B., Paul, I., Akshinthala, D., Gandarilla, O., Bose, A., Sanchez‐Gonzalez, V., Rouse, E. E., Lehoux, S. D., Pandell, N., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/513267 · Cited by 6
EXaCT-2: an augmented and customizable oncology-focused whole exome sequencing platform
Waltman, P., Chandra, P., Eng, K. W., Wilkes, D. C., Park, H. H., Pabón-Peña, C., Delpe, P., Bhinder, B., Manohar, J., Kane, T., et al. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01390-5 · Cited by 4
Surana, R., Morgado, M., Somasundaram, A., Bockorny, B., Weekes, C. D., Coleman, E. C., Bird, A., Wang, J., Williams, H. L., Zheng, H., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-25-00332 · Cited by 9
Self-citationMaloney, S., Clarke, S. J., Sahni, S., Hudson, A. L., Colvin, E. K., Mittal, A., Samra, J. S., & Pavlakis, N. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05149-4 · Cited by 6
Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy
Geerinckx, B., Teuwen, L.-A. M. N., Foo, T., Vandamme, T., Smith, A., Peeters, M., & Price, T. J. (2023) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2023.2270161 · Cited by 5
Updates in Molecular Profiling of Pancreatic Ductal Adenocarcinoma
Lee, J. J., & Yeh, J. J. (2024) · Surgical Clinics of North America · doi:10.1016/j.suc.2024.04.001 · Cited by 5
Self-citationYang, X., Luo, W., Wang, Y., Du, Y., & Yu, R. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070937 · Cited by 7
Genomic alterations in tumor tissue and ctDNA from Chinese pancreatic cancer patients.
Xiong, A., Ma, N., Wei, G., Li, C., Li, K., & Wang, B. (2021) · PubMed Central · Cited by 5
van Schaik, L. F., Engelhardt, E. G., Wilthagen, E. A., Steeghs, N., Coves, A. F., Joore, M. A., van Harten, W. H., & Retèl, V. P. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104441 · Cited by 5
Rubinson, D. A., Wolpin, B. M., Warsofsky, I. S., Ryan, D. P., Perez, K. J., Rahma, O. E., Singh, H., Yurgelun, M. B. B., Shapiro, G. I., Aguirre, A. J., et al. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-197 · Cited by 4
Self-citationArtificial Intelligence in Oncology
Jeziorski, K., & Olszewski, R. (2024) · Applied Sciences · doi:10.3390/app15010269 · Cited by 4
Toriyama, K., Masago, K., Shibata, N., Haneda, M., Kuwahara, T., Natsume, S., Kobayashi, S., Fujita, Y., Sasaki, E., Yamao, K., et al. (2025) · The Journal of Pathology · doi:10.1002/path.6432 · Cited by 4
Ishiwatari, H., Ishikawa, K., Sato, J., Niiya, F., Yasui, H., Onozawa, Y., Yamazaki, K., Todaka, A., Tsushima, T., Hamauchi, S., et al. (2025) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2025.06.042 · Cited by 4
Hossan, M. S., Lin, E. S., Riedl, E., Stram, A., Mehlhaff, E., Koeppel, L., Warner, J., Uko, I., Gettle, L. M., Lubner, S. J., et al. (2023) · Bioengineering · doi:10.3390/bioengineering10010091 · Cited by 4
Lloyd, E. G., Henríquez, J. A., & Biffi, G. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050624 · Cited by 4
Słotwiński, R., Lech, G., & Słotwińska, S. M. (2021) · Central European Journal of Immunology · doi:10.5114/ceji.2021.107027 · Cited by 4
Dissecting the molecular landscape of pancreatic cancer: towards a precision medicine approach
Pea, A., Liang Cheng, C., & Luchini, C. (2019) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2019.1604135 · Cited by 4
Precision Medicine for Pancreas Cancer Treatment: A Multidisciplinary Challenge or Opportunity?
Farrell, J. J., Robert, M. E., & Lacy, J. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.12.033 · Cited by 4
Singh, H., & Nipp, R. D. (2024) · JCO Oncology Practice · doi:10.1200/op.24.00237 · Cited by 4
Updates on molecular targets and clinical trials with targeted therapies for pancreatic cancer
Safyan, R. A., & Chiorean, E. G. (2025) · Surgical Oncology · doi:10.1016/j.suronc.2025.102268 · Cited by 3
Parassiadis, C., & Johnsen, S. A. (2026) · Gastroenterology report · doi:10.1093/gastro/goag028 · Cited by 3
Current status of cancer genome medicine for pancreatic ductal adenocarcinoma
Doi, T., Ishikawa, T., Moriguchi, M., & Itoh, Y. (2025) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaf012 · Cited by 3
Nard, B. A.-D., Geissmann, M., Akhoundova, D., Pistoni, C., Brezina, T., Zoche, M., Weber, A., Hussung, S., & Fritsch, R. (2025) · Diagnostic Pathology · doi:10.1186/s13000-025-01637-y · Cited by 4
Krepline, A. N., Geurts, J. L., Akinola, I. M., Christians, K. K., Clarke, C. N., George, B., Ritch, P. S., Khan, A. H., Hall, W. A., Erickson, B. A., et al. (2020) · HPB · doi:10.1016/j.hpb.2020.03.022 · Cited by 3
Impute Gene Expression Missing Values via Biological Networks: Optimal Fusion of Data and Knowledge
Xiang, M., Hou, J., Luo, W., Tao, W., & Wang, D. (2021) · International Joint Conference on Neural Networks (IJCNN) · doi:10.1109/ijcnn52387.2021.9533355 · Cited by 3
Akhoundova, D., Fritsch, R., & Hussung, S. (2019) · healthbook TIMES Oncology Hematology · doi:10.36000/hbt.oh.2020.05.016 · Cited by 3
Meti, N., Kelly, D., Allen, M. J., Lanys, A., Fazelzad, R., Ramjeesingh, R., Zogopoulos, G., Notta, F., Knox, J. J., Amir, E., et al. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102310 · Cited by 3
Precision Oncology in Hepatopancreatobiliary Cancer Surgery
Newhook, T. E., Tsai, S., & Meric‐Bernstam, F. (2026) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2026.05.026 · Cited by 3
Heiling, H., Rashid, N. U., Li, Q., Peng, X. L., Yeh, J. J., & Ibrahim, J. G. (2024) · Biometrics · doi:10.1093/biomtc/ujae016 · Cited by 3
Self-citationMurphy, S. J., Levy, M. J., Smadbeck, J. B., Karagouga, G., McCune, A., Harris, F. R., Udell, J. B. M., Johnson, S. H., Kerr, S. E., Cheville, J. C., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16381 · Cited by 2
Disassembly of embryonic keratin filaments promotes pancreatic cancer metastasesPreprint
Kawalerski, R. R., Gonçalves, M. T., Pan, C., Tseng, R., Roa‐Peña, L., Leiton, C. V., Torre-Healy, L. A., Boyle, T., Chowdhury, S., Snider, N. T., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.27.504988 · Cited by 3
Neoplasms of the Exocrine Pancreas
Wolff, R. A., Li, D., Maitra, A., Tsai, S., Koay, E. J., & Evans, D. B. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm094.pub2 · Cited by 3
Wenric, S., Davison, J. M., Guittar, J. L., Mayhew, G. M., Beebe, K. D., Wang, Y. E., Iyer, A. A., Kang, H. P., Milburn, M. V., Chung, V. M., et al. (2023) · medRxiv · doi:10.1101/2023.02.23.23286356 · Cited by 2
Greendyk, J. D., Allen, W. E., Alexander, H. R., Beninato, T., Eskander, M. F., Grandhi, M. S., Kennedy, T. J., Langan, R. C., Maggi, J. C., De, S., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11113058 · Cited by 3
Driving Precision Medicine in Pancreatic Cancer With Molecular Genetics
Farooq, M., & Pishvaian, M. J. (2025) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2025.08.004 · Cited by 2
Emerging Systemic Therapy Considerations for Pancreatic Cancer
Liang, K.-L., Guo, M. Z., & Zaidi, N. (2025) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2025.07.006 · Cited by 2
Yang, F., Li, L., & Kong, X. (2022) · Cancer Screening and Prevention · doi:10.14218/csp.2022.00012 · Cited by 2
Imazu, Y., Nishiwada, S., Yasuda, S., Nagai, M., Nakamura, K., Matsuo, Y., Terai, T., Yoshida, C., Kohara, Y., & Sho, M. (2023) · Journal of the American College of Surgeons · doi:10.1097/xcs.0000000000000808 · Cited by 2
Localisation hépatique isolée d’une histiocytose langerhansienne : à propos d’un cas
Allaume, P., Meneyrol, E., Bernard, G., Houssel‐Debry, P., Emile, J., & Turlin, B. (2024) · Annales de Pathologie · doi:10.1016/j.annpat.2023.12.001 · Cited by 2
Sharp, J., Jones, D., Rotow, J. K., Fidias, P. M., Bertino, E. M., & Owen, D. H. (2024) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2024.7009 · Cited by 2
Dong, S., Agarunov, E., Fasullo, M., Kim, K., Khanna, L. G., Haber, G. B., Janec, E. M., Simeone, D. M., Oberstein, P. E., & Gonda, T. A. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002786 · Cited by 2
PD-L1 expression in pancreaticobiliary adenosquamous carcinoma: a single-institution case series
Ward, J. D., Fowler, M., Robledo-Gomez, A., Goodyear, S. M., Kardosh, A., & Sasatomi, E. (2024) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-24-9 · Cited by 2
Unlocking the Genetic Secrets of Pancreatic Cancer: KRAS Allelic Imbalances in Tumor Evolution
Liaki, V., Rosas-Pérez, B., & Guerra, C. E. (2025) · Cancers · doi:10.3390/cancers17071226 · Cited by 2
Lecuelle, J., Aarnink, A., Tharin, Z., Truntzer, C., & Ghiringhelli, F. (2021) · Cancers · doi:10.3390/cancers13081851 · Cited by 2
Genomic Profiling and Potentially Targetable Alterations in Pancreatic Ductal Adenocarcinoma
Gleeson, F. C., & Levy, M. J. (2018) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-018-0195-x · Cited by 2
Moving Beyond Chemotherapy for Pancreaticobiliary Tumors: Targeted and Immunotherapy Strategies
Allen, R. S., Halpern, N., Algaze, S. D., Golan, T., El-Khoueiry, A. B., & Shroff, R. T. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_280901 · Cited by 2
Li, L., Li, X., Nong, L., Cai, W., Zhang, J., Liu, P., & Li, T. (2022) · Cancer Medicine · doi:10.1002/cam4.5557 · Cited by 2
Tarabay, A., Boilève, A., Smolenschi, C., Antoun, L., Valéry, M., Fuerea, A. C., Perret, A., Burtin, P. C., Cosconea, S., Belkhodja, H., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11092569 · Cited by 2
Mehta, A., Hwang, W. L., & Weekes, C. D. (2020) · Annals of Pancreatic Cancer · doi:10.21037/apc-2020-pda-05 · Cited by 2
Perioperative Therapy for Borderline Resectable Pancreatic Cancer: What and When?
Kim, M. P., & Katz, M. H. G. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07177-2 · Cited by 2
Blanc, S. L., Ishaque, N., Jabs, J., Bauer, T., Schuth, S., Hu, Q. F., Debnath, O., Ten, F. W., Leonhardt, C.-S., König, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.26.457743 · Cited by 2
Li, X., Xiao, C., Li, R., Zhang, P., Yang, H., & Cao, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1326556 · Cited by 1
Ex-Vivo 3D Cellular Models of Pancreatic Ductal Adenocarcinoma
Aćimović, I., Gabrielová, V., Martínková, S., Eid, M., Vlažný, J., Moravčík, P., Hlavsa, J., Moráň, L., Cakmakci, R. C., Staňo, P., et al. (2024) · Pancreas · doi:10.1097/mpa.0000000000002393 · Cited by 1
Orlandi, E., Guasconi, M., Vecchia, S., Trubini, S., Giuffrida, M., Proietto, M., Anselmi, E., Capelli, P., & Romboli, A. (2024) · Cancers · doi:10.3390/cancers16162912 · Cited by 1
Molecular Tissue Profiling in a Clinically Selected Pancreatic Cancer Cohort
Hegenberg, S., Germing, T., Schlageter, E., Ekmekçiu, I., Christmann, J., Tannapfel, A., & Reinacher‐Schick, A. (2025) · Oncology Research and Treatment · doi:10.1159/000543997 · Cited by 1
Hussung, S., Akhoundova, D., Pistoni, C., Lenggenhager, D. M., Töpfer, A., Pauli, C., Pestalozzi, B., Britschgi, C., Zoche, M., Rechsteiner, M., et al. (2025) · ESMO Gastrointestinal Oncology · doi:10.1016/j.esmogo.2025.100134 · Cited by 1
Cao, Z., Li, J., Hu, W., Xu, J., Zhao, F., Wang, Y., Qin, S., Liu, M., Wang, P., Duan, J., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404935 · Cited by 2
Gong, D. H., Guo, J. A., Su, J., Cetinkaya, S., Hennessey, C. J., Yu, P. Z., Jambhale, A. D., Wang, P. L., Caldwell, N. J., Lam, A., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117314 · Cited by 1
Self-citationHedna, R., Relave, E. T., Robin, M., Kovacic, H., & Breuzard, G. (2025) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2025.100309 · Cited by 1
Precision medicine advances in pancreatic cancer driven by genomic and molecular alterations
Li, X., Jiao, Y., & Liu, Y. (2025) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v17.i11.111264 · Cited by 1
Jung, K., Lee, J.-C., Kim, J.-H., Na, H. Y., Kim, J. H., Youn, Y., Para, N., Kim, J., & Hwang, J. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218176 · Cited by 1
Self-citationDevelopment of targeted therapy for pancreatic ductal adenocarcinoma: a 5-year review
Zhou, Z., Zhang, J., Guo, B., & Jin, H. (2025) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000244 · Cited by 1
Brügel, M., RIVIERE, V., Hubert, A., Langanay, L., Bouché, O., Génin, M., GAUTHIER, V., & Oudart, J. (2026) · Pancreatology · doi:10.1016/j.pan.2026.03.002 · Cited by 1
A Presynaptic Protein Is a Net Gain for Pancreatic Tumor Progression
Sherman, M. H. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1645 · Cited by 1
Molecular Profiling and Precision Medicine for Pancreatic Cancer
Pishvaian, M. J., & Brody, J. R. (2022) · Springer eBooks · doi:10.1007/978-3-031-05724-3_21 · Cited by 1
Barros, A. G., Mansinho, H., Couto, N., Teixeira, M. R., Tonin, F. S., Francisco, R., & Duarte‐Ramos, F. (2023) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000533178 · Cited by 1
Joris, S., Giron, P., Olsen, C., Seneca, S., Gheldof, A., Staessens, S., Shahi, R. B., Brakeleer, S. D., Teugels, E., Grève, J. D., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-12442-z · Cited by 1
Safyan, R. A., Zhang, K., Apisarnthanarax, S., Sham, J. G., Pillarisetty, V. G., Kugel, S., Dubard-Gault, M. E., Pritchard, C. C., Konnick, E. Q., Sahani, D. V., et al. (2025) · Advances in Radiation Oncology · doi:10.1016/j.adro.2025.101742 · Cited by 1
Efficient Computation of High‐Dimensional Penalized Piecewise Constant Hazard Random Effects Models
Heiling, H., Rashid, N. U., Li, Q., Peng, X. L., Yeh, J. J., & Ibrahim, J. G. (2025) · Statistics in Medicine · doi:10.1002/sim.10311 · Cited by 1
Self-citationBringing Pancreas Cancer into the Lab
Collisson, E. A. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0811 · Cited by 1
Brunton, H., Caligiuri, G., Inman, G. J., & Bailey, P. J. (2020) · Molecular and translational medicine · doi:10.1007/978-3-030-49476-6_8 · Cited by 1
Metadata
- Authors
- Aguirre, A. J., Nowak, J. A., Camarda, N. D., Moffitt, R. A., Ghazani, A. A., Hazar-Rethinam, M., Raghavan, S., Kim, J., Brais, L. K., Ragon, D., Welch, M. W., Reilly, E., McCabe, D., Marini, L., Anderka, K., Helvie, K., Oliver, N., Babic, A., Da Silva, A., Nadres, B., Van Seventer, E. E., Shahzade, H. A., St. Pierre, J. P., Burke, K. P., Clancy, T., Cleary, J. M., Doyle, L. A., Jajoo, K., McCleary, N. J., Meyerhardt, J. A., Murphy, J. E., Ng, K., Patel, A. K., Perez, K., Rosenthal, M. H., Rubinson, D. A., Ryou, M., Shapiro, G. I., Sicinska, E., Silverman, S. G., Nagy, R. J., Lanman, R. B., Knoerzer, D., Welsch, D. J., Yurgelun, M. B., Fuchs, C. S., Garraway, L. A., Getz, G., Hornick, J. L., Johnson, B. E., Kulke, M. H., Mayer, R. J., Miller, J. W., Shyn, P. B., Tuveson, D. A., Wagle, N., Yeh, J. J., Hahn, W. C., Corcoran, R. B., Carter, S. L., & Wolpin, B. M.
- Affiliations
- Broad Institute (US)
- Brigham and Women's Hospital (US)
- Stony Brook University (US)
- Massachusetts General Hospital (US)
- Dana-Farber Cancer Institute (US)
- 1Dana-Farber Cancer Institute, Boston, Massachusetts.
- 9Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
- Guardant (United States) (US)
- 14BioMed Valley Discoveries, Kansas City, Missouri.
- Harvard University (US)
- Cold Spring Harbor Laboratory (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Aguirre, Andrew J.
- Carter, Scott L.
- Wolpin, Brian M.
- ORCID
- Aguirre, Andrew J.
- Nowak, Jonathan A.
- Camarda, Nicholas D.
- Moffitt, Richard A.
- Ghazani, Arezou A.
- Hazar-Rethinam, Mehlika
- Raghavan, Srivatsan
- Kim, Jaegil
- Brais, Lauren K.
- Reilly, Emma
- McCabe, Devin
- Helvie, Karla
- Nadres, Brandon
- Burke, Kelly P.
- Clancy, Thomas
- Cleary, James M.
- Doyle, Leona A.
- McCleary, Nadine J.
- Meyerhardt, Jeffrey A.
- Ng, Kimmie
- Patel, Anuj K.
- Perez, Kimberly
- Rosenthal, Michael H.
- Rubinson, Douglas A.
- Ryou, Marvin
- Shapiro, Geoffrey I.
- Silverman, Stuart G.
- Nagy, Rebecca J.
- Lanman, Richard B.
- Knoerzer, Deborah
- Yurgelun, Matthew B.
- Fuchs, Charles S.
- Garraway, Levi A.
- Getz, Gad
- Hornick, Jason L.
- Johnson, Bruce E.
- Kulke, Matthew H.
- Mayer, Robert J.
- Miller, Jeffrey W.
- Shyn, Paul B.
- Tuveson, David A.
- Wagle, Nikhil
- Yeh, Jen Jen
- Hahn, William C.
- Corcoran, Ryan B.
- Carter, Scott L.
- Wolpin, Brian M.
- Venue
- Cancer Discovery
- Published
- 2018-09-01
- Volume
- 8
- Issue
- 9
- Pages
- 1096-1111
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC6192263
- OpenAlex
- W2808191072
- Cited by
- 367
- References
- 55
- Citations by year
- 2026: 17 · 2025: 38 · 2024: 38 · 2023: 48 · 2022: 58 · 2021: 70 · 2020: 52 · 2019: 34 · 2018: 10
- FWCI
- 15.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Funders
- Lustgarten Foundation
- Noble Effort Fund
- Peter R. Leavitt Family Fund
- Wexler Family Fund
- Promises for Purple
- HHS | NIH | National Cancer Institute (NCI) (P50CA127003, U01CA224146, U01CA210171, R01CA199064, K08CA2118420-01)
- Pancreatic Cancer Action Network (PanCAN)
- Hale Center for Pancreatic Cancer Research, Dana-Farber Cancer Institute
- Hope Funds for Cancer Research
- Doris Duke Charitable Foundation (DDCF)
- Conquer Cancer Foundation (CCF)
- Broman Fund for Pancreatic Cancer Research
- Harvard Clinical and Translational Sciences Center (UL1 TR001102)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- pancreatic ductal adenocarcinoma, advanced pancreatic cancer, precision medicine, exome sequencing, RNA sequencing, germline alterations, somatic alterations, DNA repair genes, homologous recombination deficiency, mutational signatures, MAPK inhibition, biopsy protocol, metastatic cancer
- MeSH terms
- Exome Sequencing, Adult, Aged, Aged, 80 and over, DNA Repair, Female, Humans, Male, Middle Aged, Pancreatic Neoplasms, Genetic Variation, Gene Expression Regulation, Neoplastic, Sequence Analysis, RNA, Germ-Line Mutation, Gene Expression Profiling, MAP Kinase Signaling System, Carcinoma, Pancreatic Ductal, Genomics, Gene Regulatory Networks, Precision Medicine, Homologous Recombination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
